Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec 20;12(3):1413-1429.
doi: 10.1002/fsn3.3869. eCollection 2024 Mar.

Therapeutic potential of mangiferin in cancer: Unveiling regulatory pathways, mechanisms of action, and bioavailability enhancements - An updated review

Affiliations
Review

Therapeutic potential of mangiferin in cancer: Unveiling regulatory pathways, mechanisms of action, and bioavailability enhancements - An updated review

Humaira Iqbal et al. Food Sci Nutr. .

Abstract

Mangiferin (MGF) is a phenolic compound, which is a major source of MGF is the mango tree. MGF possesses some antioxidant, anti-inflammatory, and cytoprotective properties, enabling it to play its role against various diseases such as diabetes, obesity, lung injuries, and cancer. The word "Cancer" depicts an uncontrolled and abnormal growth of cells. This review paper reveals MGF's therapeutic, curative and protective potential impact against lung, liver, ovarian, prostate, breast, stomach, and oral cancers. MGF is used in various types of research in the form of powder, liquid extract, intramuscular, intravenous, nanoparticles coated with gold, in the form of a solution, or in combination with other drugs to evaluate synergistic effects. Many studies showed that MGF is safe to use but has less bioavailability in the body and 0.111 mg/mL solubility in water. However, certain studies indicated that its bioavailability and retention time increased when taken in the form of nanoparticles and in combination with other drugs. MGF also increases the sensitivity of other drugs (i.e., cisplatin) resistant to tumors. MGF has different mechanisms of action for different cancers. It mainly targets enzymes, interleukins, tumor growth factors, signaling pathways, apoptotic proteins, and genes to inhibit the growth of tumors, volume, angiogenesis, cellular functionality, further progression, and movement to other areas of the body. Moreover, MGF increases apoptosis and body weight with no or fewer side effects on normal cells. MGF unveiled a novel gate toward the treatment of cancer. Further research and human trials are needed in this regard.

Keywords: angiogenesis; anticancer; antiproliferative; anti‐inflammatory; apoptosis; mangiferin.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

FIGURE 1
FIGURE 1
Structural formula of MGF (molecular formula: C19H18O11).
FIGURE 2
FIGURE 2
MGF mechanism against cancer.
FIGURE 3
FIGURE 3
MGF modulation of the immune system.
FIGURE 4
FIGURE 4
MGF's mechanism of action with other drugs.

Similar articles

Cited by

References

    1. Aboyewa, J. A. , Sibuyi, N. R. , Meyer, M. , & Oguntibeju, O. O. (2021). Gold nanoparticles synthesized using extracts of cyclopia intermedia, commonly known as honeybush, amplify the cytotoxic effects of doxorubicin. Nanomaterials, 11(1), 132. - PMC - PubMed
    1. Adoho, A. C. C. , Konmy, B. B. S. , Olounladé, P. A. , Azando, E. V. , Hounzangbé‐Adoté, M. S. , & Gbangboché, B. A. (2022). Phytochemistry and larval toxicity of Ipomea asarifolia, Commelina diffusa, Acalypha ciliata and Eleusine indica against Artemia salina . International Journal of Veterinary Science, 11(2), 121–128.
    1. Akhtar, T. , Shahid, S. , Asghar, A. , Naeem, M. I. , Aziz, S. , & Ameer, T. (2023). Utilisation of herbal bullets against Newcastle disease in poultry sector of Asia and Africa (2012–2022). International Journal of Agriculture and Biosciences, 12(1), 56–65.
    1. AlMasri, S. , Zenati, M. , Hammad, A. , Nassour, I. , Liu, H. , Hogg, M. E. , Zeh, H. J. , Boone, B. , Bahary, N. , Singhi, A. D. , Lee, K. K. , Paniccia, A. , & Zureikat, A. H. (2022). Adaptive dynamic therapy and survivorship for operable pancreatic cancer. JAMA Network Open, 5(6), e2218355. - PMC - PubMed
    1. Balasar, M. , Özkent, M. S. , Aydin, A. , Taskapu, H. H. , Atici, A. , Ecer, G. , & Sonmez, M. G. (2022). The benign renal masses that were exposed after nephron‐sparing surgery: “postsurgical fatty tumor.” Is it related to the surgical technique? Journal of Kidney Cancer and VHL, 9(1), 1. - PMC - PubMed

LinkOut - more resources